Skip to content
OpenCapital
Get started

Ardent Health Partners ARDT Trading securities, cost

Other financials

Income statement

See full
Revenue$1.6B+7.0%
Gross profit$1.6B+6.7%
Net income$39.9M-3.7%
EPS (diluted)$0.28-3.4%

Balance sheet

See full
Cash & equivalents$609.7M+23.2%
Total debt$1.2B+1.7%
Total equity$1.3B+13.8%
Total assets$5.3B+7.0%

Cash flow

See full
Operating cash flow-$60.2M-143%
CapEx$28.1M+22.6%
Free cash flow-$88.3M-85.2%

Valuation

See full
Market cap$1.35B-27.8%
Enterprise value$1.91B-24.3%
P/E10×+1.7×
P/S0.2×-0.1×

Profitability

See full
Gross margin97.5%-0.1pp
Net margin2.1%-1.6pp
FCF margin3.4%+1.4pp

Returns & leverage

See full
Return on equity10.7%-9.0pp
Debt / equity0.9×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Ardent Health Partners in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Ardent Health Partners’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardent Health Partners's trading securities, cost.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardent Health Partners's trading securities, cost?
Ardent Health Partners (ARDT) reported trading securities, cost of $18.8M in Q1 2026.